Volume-Based Procurement in Mainland China: Key Trends and Planning Future Strategies

Volume-Based Procurement in Mainland China: Key trends and planning future strategies Infectious disease and nervous system therapies comprise most of the drugs contracted through VBP ‣ Clarivate™ Overview of drugs negotiated successfully, by therapeutic area 13% 18% 4% 8% 157 drugs as of 9% April 2021 18% 14% 16% ■Infectious disease ■Cardiovascular disease ■Cancer and immuno-modulators ■ Blood products ■Nervous system disease Digestive/metabolic diseases ■Respiratory system ■ Others* Source: GBI analysis, Clarivate 3

View entire presentation